Wuxi AppTec and Pfizer contributed to a series A round that will support progress of Simcha Therapeutics' immuno-oncology treatments toward clinical trials.

Simcha Therapeutics, a US-based cancer therapeutics developer spun out of Yale University, has received $25m of series A funding from investors including pharmaceutical firms Pfizer and WuXi AppTec. The round also featured venture capital firm Sequoia Capital China and Connecticut Innovations, the strategic venturing arm of the US state of Connecticut, while WuXi AppTec invested…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.